Quarterly report pursuant to Section 13 or 15(d)

EARNINGS (LOSS) PER SHARE (Tables)

v3.24.1.u1
EARNINGS (LOSS) PER SHARE (Tables)
3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share
The reconciliations of the net loss and the weighted average number of shares used in the computations of basic and diluted loss per share are as follows:
Three Months Ended March 31,
2024 2023
Numerator:
Net loss and comprehensive loss
$ (18,355) $ (12,440)
Net loss and comprehensive loss - diluted
$ (18,355) $ (12,440)
Denominator:
Weighted-average shares of common stock - basic 195,131,642  194,050,835 
Weighted-average shares of common stock - diluted 195,131,642  194,050,835 
Loss per common share:
Basic $ (0.09) $ (0.06)
Diluted $ (0.09) $ (0.06)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following table summarizes weighted average instruments that may, in the future, have a dilutive effect on earnings (loss) per share, but were excluded from consideration in the computation of diluted net loss per share for the three months ended March 31, 2024 and 2023, because the impact of including them would have been anti-dilutive:
Three Months Ended March 31,
2024 2023
Stock options 27,653,611  28,615,308 
Warrants (derivative liabilities and equity) 88,052,437  85,989,948 
Unvested restricted stock awards 1,861  1,120,815 
115,707,909  115,726,071